Boven Annelies, Versporten Ann, Pauwels Ines, Oshun Philip, Oduyebo Oyinlola, Keustermans Jimmy, Brusselaers Nele, Vlieghe Erika
Department of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.
Department of Medical Microbiology and Parasitology, College of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria.
JAC Antimicrob Resist. 2025 Jul 4;7(4):dlaf115. doi: 10.1093/jacamr/dlaf115. eCollection 2025 Aug.
Many tools for antimicrobial use surveillance have been exclusively developed for inpatient settings, although >80% of all antimicrobials are prescribed in outpatient care. In this study, we describe the methodology and first evaluation of the outpatient Global Point Prevalence Survey (Global-PPS).
Global-PPS developed a standardized tool to measure outpatient antimicrobial prescribing patterns. A core set of variables was collected for all ambulatory patients, and more detailed data for those prescribed antimicrobials during the survey. A questionnaire containing 34 questions on experiences with the outpatient Global-PPS was administered to users who had used the outpatient module of the Global-PPS between May 2023 and December 2024.
In total, 39 (29.1%) participants of the outpatient Global-PPS from 25 (71.4%) different healthcare facilities responded to the questionnaire, of which 25 (from 16 facilities) completed it. Most respondents were from Nigeria (50%), Ghana (12.5%) or Guinea (10%).Respondent satisfaction was very high (>90%, = 25), although additional training and support tools seemed to be needed. Most facilities (75%, = 16) encountered certain barriers to conducting the survey, including challenges in obtaining patient information during consultation (44%) or accessing medical records (28%), and a lack of trained staff (16%).
The outpatient Global-PPS is the first freely available web-based standardized tool for measuring antimicrobial use in outpatient care worldwide, featuring an online data entry platform, validation and real-time reporting. This study confirmed a high degree of satisfaction among participants, although additional support is needed to train staff and overcome certain barriers, including access to patient information.
许多抗菌药物使用监测工具专门为住院环境开发，然而所有抗菌药物中超过80%是在门诊开具的。在本研究中，我们描述了门诊全球点患病率调查（Global-PPS）的方法及首次评估。
Global-PPS开发了一个标准化工具来衡量门诊抗菌药物处方模式。为所有门诊患者收集了一组核心变量，并为调查期间开具抗菌药物的患者收集了更详细的数据。向在2023年5月至2024年12月期间使用过Global-PPS门诊模块的用户发放了一份包含34个关于门诊Global-PPS使用体验问题的问卷。
来自25个（71.4%）不同医疗机构的39名（29.1%）门诊Global-PPS参与者回复了问卷，其中25名（来自16个机构）完成了问卷。大多数受访者来自尼日利亚（50%）、加纳（12.5%）或几内亚（10%）。受访者满意度非常高（>90%，n = 25），尽管似乎需要额外的培训和支持工具。大多数机构（75%，n = 16）在开展调查时遇到了某些障碍，包括在会诊期间获取患者信息方面的挑战（44%）或获取病历方面的困难（28%），以及缺乏训练有素的工作人员（16%）。
门诊Global-PPS是首个免费的基于网络的全球门诊抗菌药物使用测量标准化工具，具有在线数据录入平台、验证和实时报告功能。本研究证实参与者满意度很高，尽管需要额外支持来培训工作人员并克服某些障碍，包括获取患者信息。
